{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T02:13:06Z","timestamp":1781575986925,"version":"3.54.5"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T00:00:00Z","timestamp":1715299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T00:00:00Z","timestamp":1715299200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Ther"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1007\/s40120-024-00628-3","type":"journal-article","created":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T11:01:56Z","timestamp":1715338916000},"page":"965-973","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Fake Xanax: Designer Emerging Benzodiazepine Epidemic Linked to Morbidity and Mortality a Narrative Review"],"prefix":"10.1007","volume":"13","author":[{"given":"Alan D.","family":"Kaye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph P.","family":"Tassin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William C.","family":"Upshaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille M.","family":"Robichaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark V.","family":"Frolov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark M.","family":"Dupaquier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia E.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Sterritt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jibin","family":"Mathew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4545-4523","authenticated-orcid":false,"given":"Sahar","family":"Shekoohi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam M.","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber N.","family":"Edinoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,10]]},"reference":[{"key":"628_CR1","unstructured":"Bounds CG, Nelson VL. Benzodiazepines. Treasure Island: StatPearls; 2024. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK470159\/. Accessed Feb 4, 2024."},{"issue":"9","key":"628_CR2","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1038\/mp.2012.139","volume":"18","author":"DH Wolf","year":"2013","unstructured":"Wolf DH, Pinkham AE, Satterthwaite TD, et al. Oral alprazolam acutely increases nucleus accumbens perfusion. Mol Psychiatry. 2013;18(9):960\u20131. https:\/\/doi.org\/10.1038\/mp.2012.139.","journal-title":"Mol Psychiatry"},{"issue":"2","key":"628_CR3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3390\/jcm7020017","volume":"7","author":"J Guina","year":"2018","unstructured":"Guina J, Merrill B. Benzodiazepines I: upping the care on downers: the evidence of risks, benefits and alternatives. J Clin Med. 2018;7(2):17. https:\/\/doi.org\/10.3390\/jcm7020017.","journal-title":"J Clin Med"},{"issue":"10","key":"628_CR4","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1080\/10826084.2021.1936046","volume":"56","author":"B Stickle","year":"2021","unstructured":"Stickle B. A high note: drug misuse in popular rap music. Subst Use Misuse. 2021;56(10):1448\u201356. https:\/\/doi.org\/10.1080\/10826084.2021.1936046.","journal-title":"Subst Use Misuse"},{"issue":"4","key":"628_CR5","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1111\/dar.13052","volume":"39","author":"S Nielsen","year":"2020","unstructured":"Nielsen S, McAuley A. Etizolam: a rapid review on pharmacology, non-medical use and harms. Drug Alcohol Rev. 2020;39(4):330\u20136. https:\/\/doi.org\/10.1111\/dar.13052.","journal-title":"Drug Alcohol Rev"},{"key":"628_CR6","unstructured":"ETIZOLAM (Trade Names: Etilaam, Etizest, Depas, Etizola, Sedekopan, Pasaden). https:\/\/www.deadiversion.usdoj.gov\/drug_chem_info\/etizolam.pdf"},{"key":"628_CR7","unstructured":"World Health Organization. WHO Expert Committee on Drug Dependence: Forty-Second Report. World Health Organization; 2020. https:\/\/iris.who.int\/handle\/10665\/331486. Accessed Feb 20, 2024."},{"key":"628_CR8","doi-asserted-by":"publisher","unstructured":"Tahara T, Araki K, Shiroki M, Matsuo H, Munakata T. ChemInform Abstract: syntheses and structure-activity relationships 6-aryl-4H-s-triazolo(3,4-c)thieno(2,3-e)(1,4)diazepines. Chemischer Informationsdienst. 1978;9(44). https:\/\/doi.org\/10.1002\/chin.197844214.","DOI":"10.1002\/chin.197844214"},{"issue":"6","key":"628_CR9","doi-asserted-by":"publisher","first-page":"655","DOI":"10.4103\/0253-7613.144943","volume":"46","author":"S Gupta","year":"2014","unstructured":"Gupta S, Garg B. A case of etizolam dependence. Indian J Pharmacol. 2014;46(6):655\u20136. https:\/\/doi.org\/10.4103\/0253-7613.144943.","journal-title":"Indian J Pharmacol"},{"issue":"5","key":"628_CR10","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.drugpo.2014.10.010","volume":"26","author":"A McAuley","year":"2015","unstructured":"McAuley A, Hecht G, Barnsdale L, et al. Mortality related to novel psychoactive substances in Scotland, 2012: an exploratory study. Int J Drug Policy. 2015;26(5):461\u20137. https:\/\/doi.org\/10.1016\/j.drugpo.2014.10.010.","journal-title":"Int J Drug Policy"},{"key":"628_CR11","doi-asserted-by":"publisher","unstructured":"Pathak R, Gaur V, Sankrityayan H, Gogtay J. Tackling counterfeit drugs: the challenges and possibilities. Pharmaceut Med. 2023. https:\/\/doi.org\/10.1007\/s40290-023-00468-w.","DOI":"10.1007\/s40290-023-00468-w"},{"key":"628_CR12","unstructured":"Dowd FJ. In: Johnson BS, Mariotti AJ, editors. Pharmacology and therapeutics for dentistry. 7th edition. Elsevier; 2017."},{"issue":"9","key":"628_CR13","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1007\/s40263-022-00940-2","volume":"36","author":"R Kienitz","year":"2022","unstructured":"Kienitz R, Kay L, Beuchat I, et al. Benzodiazepines in the management of seizures and status epilepticus: a review of routes of delivery, pharmacokinetics, efficacy, and tolerability. CNS Drugs. 2022;36(9):951\u201375. https:\/\/doi.org\/10.1007\/s40263-022-00940-2.","journal-title":"CNS Drugs"},{"issue":"3","key":"628_CR14","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1002\/(SICI)1099-1077(199605)11:3<225::AID-HUP791>3.0.CO;2-2","volume":"11","author":"R Silvestri","year":"1996","unstructured":"Silvestri R, Ferrillo F, Murri L, et al. Rebound insomnia after abrupt discontinuation of hypnotic treatment: double-blind randomized comparison of zolpidem versus triazolam. Hum Psychopharmacol Clin Exp. 1996;11(3):225\u201333. https:\/\/doi.org\/10.1002\/(SICI)1099-1077(199605)11:3%3c225::AID-HUP791%3e3.0.CO;2-2.","journal-title":"Hum Psychopharmacol Clin Exp"},{"key":"628_CR15","unstructured":"Sharbaf Shoar N, Bistas KG, Saadabadi A. Flumazenil. Treasure Island: StatPearls. 2024. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK470180\/. Accessed Feb 20, 2024."},{"key":"628_CR16","unstructured":"PubChem. Etizolam. https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/3307. Accessed Feb 12, 2024."},{"issue":"9","key":"628_CR17","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1177\/0269881119901096","volume":"34","author":"S El Balkhi","year":"2020","unstructured":"El Balkhi S, Monchaud C, Herault F, G\u00e9niaux H, Saint-Marcoux F. Designer benzodiazepines\u2019 pharmacological effects and potencies: how to find the information. J Psychopharmacol. 2020;34(9):1021\u20139. https:\/\/doi.org\/10.1177\/0269881119901096.","journal-title":"J Psychopharmacol"},{"key":"628_CR18","unstructured":"Ghiasi N, Bhansali RK, Marwaha R. Lorazepam. Treasure Island: StatPearls. 2024. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK532890\/. Accessed Feb 12, 2024."},{"key":"628_CR19","doi-asserted-by":"publisher","first-page":"263235241989552","DOI":"10.1177\/2632352419895527","volume":"14","author":"E Prommer","year":"2020","unstructured":"Prommer E. Midazolam: an essential palliative care drug. Palliat Care Soc Pract. 2020;14:2632352419895527. https:\/\/doi.org\/10.1177\/2632352419895527.","journal-title":"Palliat Care Soc Pract"},{"key":"628_CR20","unstructured":"George TT, Tripp J. Alprazolam. Treasure Island: StatPearls. 2024. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK538165\/. Accessed Feb 12, 2024."},{"key":"628_CR21","unstructured":"Dhaliwal JS, Rosani A, Saadabadi A. Diazepam. Treasure Island: StatPearls. 2024. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK537022\/. Accessed Feb 12, 2024."},{"issue":"2","key":"628_CR22","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s11419-022-00616-y","volume":"40","author":"KR Manchester","year":"2022","unstructured":"Manchester KR, Waters L, Haider S, Maskell PD. The blood-to-plasma ratio and predicted GABAA-binding affinity of designer benzodiazepines. Forensic Toxicol. 2022;40(2):349\u201356. https:\/\/doi.org\/10.1007\/s11419-022-00616-y.","journal-title":"Forensic Toxicol"},{"issue":"2","key":"628_CR23","first-page":"483","volume":"12","author":"MT Beigmohammadi","year":"2013","unstructured":"Beigmohammadi MT, Hanifeh M, Rouini MR, Sheikholeslami B, Mojtahedzadeh M. Pharmacokinetics alterations of midazolam infusion versus bolus administration in mechanically ventilated critically ill patients. Iran J Pharm Res. 2013;12(2):483\u20138.","journal-title":"Iran J Pharm Res"},{"key":"628_CR24","doi-asserted-by":"publisher","unstructured":"Araki K, Yasui-Furukori N, Fukasawa T, et al. Inhibition of the metabolism of etizolam by itraconazole in humans: evidence for the involvement of CYP3A4 in etizolam metabolism. Eur J Clin Pharmacol. 2004;60(6). https:\/\/doi.org\/10.1007\/s00228-004-0789-1.","DOI":"10.1007\/s00228-004-0789-1"},{"issue":"3","key":"628_CR25","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1080\/15563650.2018.1506130","volume":"57","author":"M B\u00e4ckberg","year":"2019","unstructured":"B\u00e4ckberg M, Pettersson Bergstrand M, Beck O, Helander A. Occurrence and time course of NPS benzodiazepines in Sweden\u2014results from intoxication cases in the STRIDA project. Clin Toxicol. 2019;57(3):203\u201312. https:\/\/doi.org\/10.1080\/15563650.2018.1506130.","journal-title":"Clin Toxicol"},{"key":"628_CR26","unstructured":"Public Health Scotland. The National Drug-Related Deaths Database (Scotland) Report: analysis of deaths occurring in 2017 and 2018. https:\/\/publichealthscotland.scot\/publications\/national-drug-related-death-database-scotland\/the-national-drug-related-deaths-database-scotland-report-analysis-of-deaths-occurring-in-2017-and-2018\/. Accessed Feb 20, 2024."},{"issue":"10","key":"628_CR27","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1001\/jamainternmed.2016.4306","volume":"176","author":"AM Arens","year":"2016","unstructured":"Arens AM, van Wijk XMR, Vo KT, Lynch KL, Wu AHB, Smollin CG. Adverse effects from counterfeit alprazolam tablets. JAMA Intern Med. 2016;176(10):1554\u20135. https:\/\/doi.org\/10.1001\/jamainternmed.2016.4306.","journal-title":"JAMA Intern Med"},{"issue":"2","key":"628_CR28","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1177\/0025802420973814","volume":"61","author":"LJ Hikin","year":"2021","unstructured":"Hikin LJ, Smith PR, Maskell PD, et al. Femoral blood concentrations of the designer benzodiazepine etizolam in post-mortem cases. Med Sci Law. 2021;61(2):122\u20139. https:\/\/doi.org\/10.1177\/0025802420973814.","journal-title":"Med Sci Law"},{"issue":"2","key":"628_CR29","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s11419-020-00568-1","volume":"39","author":"K Nowak","year":"2021","unstructured":"Nowak K, Szpot P, Zawadzki M. Fatal intoxication with U-47700 in combination with other NPS (N-ethylhexedrone, adinazolam, 4-CIC, 4-CMC) confirmed by identification and quantification in autopsy specimens and evidences. Forensic Toxicol. 2021;39(2):493\u2013505. https:\/\/doi.org\/10.1007\/s11419-020-00568-1.","journal-title":"Forensic Toxicol"},{"issue":"3","key":"628_CR30","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1093\/jat\/bkaa070","volume":"45","author":"DM Papsun","year":"2021","unstructured":"Papsun DM, Krotulski AJ, Homan J, Temporal KDH, Logan BK. Flualprazolam blood concentrations in 197 forensic investigation cases. J Anal Toxicol. 2021;45(3):226\u201332. https:\/\/doi.org\/10.1093\/jat\/bkaa070.","journal-title":"J Anal Toxicol"},{"key":"628_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2019.109959","volume":"303","author":"S Lehmann","year":"2019","unstructured":"Lehmann S, Sczyslo A, Froch-Cortis J, et al. Organ distribution of diclazepam, pyrazolam and 3-fluorophenmetrazine. Forensic Sci Int. 2019;303:109959. https:\/\/doi.org\/10.1016\/j.forsciint.2019.109959.","journal-title":"Forensic Sci Int"},{"issue":"3","key":"628_CR32","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1002\/dta.3119","volume":"14","author":"K Blakey","year":"2022","unstructured":"Blakey K, Thompson A, Matheson A, Griffiths A. What\u2019s in fake \u2018Xanax\u2019?: A dosage survey of designer benzodiazepines in counterfeit pharmaceutical tablets. Drug Test Anal. 2022;14(3):525\u201330. https:\/\/doi.org\/10.1002\/dta.3119.","journal-title":"Drug Test Anal"},{"issue":"6","key":"628_CR33","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.psym.2019.02.007","volume":"60","author":"AP Shapiro","year":"2019","unstructured":"Shapiro AP, Krew TS, Vazirian M, Jerry J, Sola C. Novel ways to acquire designer benzodiazepines: a case report and discussion of the changing role of the internet. Psychosomatics. 2019;60(6):625\u20139. https:\/\/doi.org\/10.1016\/j.psym.2019.02.007.","journal-title":"Psychosomatics"},{"key":"628_CR34","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.forsciint.2016.09.006","volume":"268","author":"G H\u00f8iseth","year":"2016","unstructured":"H\u00f8iseth G, Tuv SS, Karinen R. Blood concentrations of new designer benzodiazepines in forensic cases. Forensic Sci Int. 2016;268:35\u20138. https:\/\/doi.org\/10.1016\/j.forsciint.2016.09.006.","journal-title":"Forensic Sci Int"},{"issue":"4","key":"628_CR35","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.annemergmed.2014.12.019","volume":"65","author":"CW O\u2019Connell","year":"2015","unstructured":"O\u2019Connell CW, Sadler CA, Tolia VM, Ly BT, Saitman AM, Fitzgerald RL. Overdose of etizolam: the abuse and rise of a benzodiazepine analog. Ann Emerg Med. 2015;65(4):465\u20136. https:\/\/doi.org\/10.1016\/j.annemergmed.2014.12.019.","journal-title":"Ann Emerg Med"},{"key":"628_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2022.111324","volume":"336","author":"G Drevin","year":"2022","unstructured":"Drevin G, Briet M, Ferec S, Abbara C. Toxicity of designer benzodiazepines: a case of etizolam and cocaine intoxication. Forensic Sci Int. 2022;336:111324. https:\/\/doi.org\/10.1016\/j.forsciint.2022.111324.","journal-title":"Forensic Sci Int"},{"issue":"5","key":"628_CR37","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s00414-020-02352-7","volume":"134","author":"V Kolbe","year":"2020","unstructured":"Kolbe V, Rentsch D, Boy D, Schmidt B, Kegler R, B\u00fcttner A. The adulterated XANAX pill: a fatal intoxication with etizolam and caffeine. Int J Legal Med. 2020;134(5):1727\u201331. https:\/\/doi.org\/10.1007\/s00414-020-02352-7.","journal-title":"Int J Legal Med"},{"key":"628_CR38","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.jpeds.2020.12.075","volume":"232","author":"JS Love","year":"2021","unstructured":"Love JS, Thompson JA, Horowitz BZ. \u201cPressed etizolam\u201d. J Pediatrics. 2021;232:303\u20134. https:\/\/doi.org\/10.1016\/j.jpeds.2020.12.075.","journal-title":"J Pediatrics"},{"issue":"3","key":"628_CR39","doi-asserted-by":"publisher","first-page":"648","DOI":"10.3390\/neurolint14030053","volume":"14","author":"AN Edinoff","year":"2022","unstructured":"Edinoff AN, Nix CA, Odisho AS, et al. Novel designer benzodiazepines: comprehensive review of evolving clinical and adverse effects. Neurol Int. 2022;14(3):648\u201363.","journal-title":"Neurol Int"}],"container-title":["Neurology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-024-00628-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40120-024-00628-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-024-00628-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T06:24:53Z","timestamp":1721629493000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40120-024-00628-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,10]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["628"],"URL":"https:\/\/doi.org\/10.1007\/s40120-024-00628-3","relation":{},"ISSN":["2193-8253","2193-6536"],"issn-type":[{"value":"2193-8253","type":"print"},{"value":"2193-6536","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,10]]},"assertion":[{"value":"26 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Alan D Kaye, Joseph P Tassin, William C Upshaw, Camille M Robichaux, Mark V Frolov, Mark M Dupaquier, Julia E Fox, Jeffrey Sterritt, Jibin Mathew, Sahar Shekoohi, Adam M Kaye and Amber N Edinoff have no conflict of interest. Alan D Kaye is an Editorial Board member of<i> Pain and Therapy<\/i>. Alan D Kaye was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article is based on previous studies and contains no new studies with human participants or animals performed by any authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}